We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The heart system may now be used in patients who cannot handle maximal medical therapy or a left ventricular-assist device and who are likely to undergo heart transplant within 180 days after implantation, the company said. Read More
Strados is collaborating with research organizations and drugmakers to capture lung-sound measurements as endpoints in their clinical trials. Read More
The FDA granted the designation based on pre-clinical data from its animal studies and clinical data collected in its first in-human feasibility trial. Read More
The company will now launch the test in Europe for use in healthcare settings, including clinics and emergency rooms, and will initiate trials evaluating its over-the-counter use. Read More